XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation (Tables)
6 Months Ended
Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

 

  

Shares

Underlying

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

(In Years)

 
Outstanding as of April 30, 2021   516,827   $3.89    9.0 
Granted      $      
Exercised   (6,666)  $1.05      
Expired   (1,806)  $32.62      
Cancelled/forfeited   (110,382)  $2.58      
Outstanding as of October 31, 2021   397,973   $4.16    8.4 
Exercisable as of October 31, 2021   239,780   $4.98    7.8 
Schedule of Business Acquisition and Fair Value of Net Assets, Compensation Expense Recognized

 

      
Fair Value of Purchase  $1,161,267 
Total Acquired Assets  $(593,571)
Total Acquired Liabilities  $117,106 
Compensation Expense  $684,802 
Quarterly Compensation Expense  $171,201 
Schedule of Non-vested Restricted Stock Activity

A summary of non-vested restricted stock under our stock incentive plans is as follows:

 

 

  

Number

of Shares

  

Weighted

Average Price
per Share

 
Issued and unvested at April 30, 2021   10,000   $2.93 
Granted   33,333   $2.37 
Vested      $ 
Cancelled/forfeited      $ 
Issued and unvested at October 31, 2021   43,333   $2.50 
Performance Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

 

  

Shares

Underlying

Options

   Weighted
Average
Exercise
Price
  

Weighted

Average

Remaining

Contractual

Term

(In Years)

 
Outstanding as of April 30, 2021   424,790   $2.57    9.5 
Granted   66,667   $0.62      
Exercised   (13,334)  $1.05      
Cancelled/forfeited   (193,433)  $2.80      
Outstanding as of October 31, 2021   284,690   $2.03    9.1 
Exercisable as of October 31, 2021   27,334   $1.05    8.2